Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma

Transarterial radioembolization (TARE) is a well‐established therapy for intermediate and advanced tumor stages of hepatocellular carcinoma (HCC). Treatment‐associated toxicities are rare. Previous studies have outlined that the prognosis after TARE is determined primarily by tumor stage and liver f...

Descripción completa

Detalles Bibliográficos
Autores principales: Reincke, Marlene, Schultheiss, Michael, Doppler, Michael, Verloh, Niklas, Uller, Wibke, Sturm, Lukas, Thimme, Robert, Goetz, Christian, Bettinger, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592795/
https://www.ncbi.nlm.nih.gov/pubmed/36064940
http://dx.doi.org/10.1002/hep4.2072

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592795/
https://www.ncbi.nlm.nih.gov/pubmed/36064940
http://dx.doi.org/10.1002/hep4.2072

Ejemplares similares